Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 1.56
2.63 %
$ 16.4 M
Market Cap
-13.0
P/E
CASH FLOW STATEMENT
827 K
OPERATING CASH FLOW
-75 K
INVESTING CASH FLOW
-79 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Nephros, Inc.
| Net Income | -1.58 M |
| Depreciation & Amortization | 214 K |
| Capital Expenditures | -75 K |
| Stock-Based Compensation | 1.05 M |
| Change in Working Capital | 830 K |
| Others | 837 K |
| Free Cash Flow | 752 K |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||||||
| Net Income | (1.6) | (7.1) | (3.9) | (4.5) | (3.2) | (3.3) | (0.8) | (3.0) | (3.1) | (7.4) | (3.7) | (3.3) | (2.4) | (1.9) | (2.0) | (6.3) | (26.4) | (8.0) | (5.5) | (7.6) | (5.6) | (2.4) | 0 |
| Depreciation & Amortization | 0.2 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 9 K | 91 K | 0.1 | 0.2 | 0.4 | 4.9 | 0.4 | 0.3 | 0.2 | 0.6 | 1.3 | 0 |
| Deferred Income Tax | 0 | 0 | (0.3) | 32 K | 56 K | 0.3 | 0 | (0.6) | 8 K | 0.3 | 0.5 | 94 K | 2.4 | 50 K | 0 | (0.3) | (1.2) | (0.4) | (0.4) | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 1.1 | 1.0 | 1.3 | 0.8 | 1.3 | 1.0 | 0.8 | 0.6 | 0.5 | 0.4 | 0.6 | 0.4 | 0.3 | 92 K | 0.1 | 0.2 | 0.9 | 0.5 | 0.4 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 0.3 | 2.3 | 0.3 | 97 K | (0.1) | 45 K | 0.1 | 0.7 | (0.3) | 4.3 | 53 K | 82 K | (2.1) | 48 K | 18 K | 0.3 | 14.3 | 0.5 | (0.2) | 0.8 | 1.9 | (0.8) | 0 |
| Change in Working Capital | 0.8 | 0.2 | 0.9 | (3.5) | (0.6) | (1.9) | (0.4) | 18 K | (1.2) | (0.4) | (1.2) | 1.1 | 0.5 | 0.3 | (0.9) | 10 K | 19 K | (0.2) | 0.3 | (1.2) | (0.4) | 0.2 | 0 |
| Cash From Operations | 0.8 | (3.2) | (1.4) | (6.9) | (2.3) | (3.7) | 77 K | (2.1) | (3.8) | (2.5) | (3.6) | (1.5) | (1.3) | (1.3) | (2.6) | (5.7) | (7.4) | (7.3) | (5.1) | (7.8) | (3.4) | (1.8) | 0 |
| INVESTING CASH FLOW | |||||||||||||||||||||||
| Capital Expenditures | 75 K | (0.1) | 36 K | (0.2) | 14 K | 0 | 0 | 45 K | 13 K | 0 | 0 | (0.7) | 0 | 30 K | 28 K | 97 K | (0.1) | (0.1) | (0.4) | (0.9) | (0.5) | 30.8 K | 0 |
| Other Items | 0 | 0 | 49 K | 0 | (0.1) | (1.0) | 0 | 0 | 0 | 0 | 3 K | 47 K | 0 | 0 | 7 K | 4.7 | (1.9) | 1.7 | 1.5 | (6.0) | 0 | 0 | 0 |
| Cash From Investing Activities | 75 K | (0.1) | 85 K | (0.2) | (0.2) | (1.0) | 0 | 45 K | 13 K | 0 | 3 K | (0.6) | 0 | 30 K | 21 K | 4.6 | (2.0) | 1.6 | 1.1 | (6.9) | (0.5) | 30.8 K | 0 |
| FINANCING CASH FLOW | |||||||||||||||||||||||
| Common Stock Repurchased | 0 | 31 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 79 K | (0.3) | (0.3) | (0.3) | (0.6) | 0.1 | 0.7 | 1.2 | 0 | (1.7) | 1.5 | 0 | (0.6) | 0.5 | 0 | 0 | 12.7 | 5.2 | 0 | 0 | 0.8 | 1.8 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.3) | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0.3 | 0.5 | 85 K | 0.7 | 3.1 | 100 K | 1 K | 2.5 | 15 K | (0.2) | 0.5 | 0.2 | 72 K | 85 K | 0 | 0 | 882 | 0 | 0 | 0 | 30 K | 0 |
| Cash From Financing Activities | 79 K | 34 K | 0.2 | 11.2 | 2.0 | 7.0 | 2.0 | 1.2 | 3.8 | 3.2 | 4.1 | 0.5 | 2.7 | 0.6 | 1.3 | 0 | 12.7 | 5.2 | 1.0 | 14.3 | 7.6 | 1.8 | 0 |
| CHANGE IN CASH | |||||||||||||||||||||||
| Net Change In Cash | 0.7 | (3.3) | (1.3) | 4.1 | (0.4) | 2.4 | 1.9 | (1.0) | 36 K | 0.7 | 0.5 | (1.6) | 1.4 | (0.8) | (1.3) | (1.1) | 3.2 | (0.5) | (3.0) | (0.4) | 3.9 | 37.1 K | 0 |
| FREE CASH FLOW | |||||||||||||||||||||||
| Free Cash Flow | 0.8 | (3.4) | (1.5) | (7.1) | (2.3) | (3.7) | 77 K | (2.2) | (3.8) | (2.5) | (3.6) | (2.2) | (1.3) | (1.3) | (2.6) | (5.8) | (7.6) | (7.4) | (5.4) | (8.7) | (3.9) | (1.8) | 0 |